• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

替加环素对艰难梭菌感染结局的影响：病例系列和倾向评分匹配回顾性研究。

Impact of Tigecycline on C. difficile Outcomes: Case Series and Propensity-Matched Retrospective Study.

机构信息

University of Virginiagrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.

Division of Infectious Diseases & International Health, Department of Medicine, University of Virginiagrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.

出版信息

Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0000122. doi: 10.1128/aac.00001-22. Epub 2022 Jun 1.

DOI:10.1128/aac.00001-22
PMID:35647645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9211400/
Abstract

This case series and propensity-matched cohort study on the use of tigecycline in Clostridioides difficile infection (CDI) evaluated the effect of tigecycline on 30-day mortality. Adjusted for ATLAS Score, hypotension, treatment time period, and serum lactate, tigecycline did not significantly improve 30-day mortality (odds ratio: 0.89; 95% confidence interval: 0.25-3.12; 0.853). A randomized controlled trial is needed to determine efficacy and safety of tigecycline in severe or refractory CDI.

摘要

本病例系列和倾向评分匹配队列研究评估了替加环素在艰难梭菌感染（CDI）中的应用对 30 天死亡率的影响。调整 ATLAS 评分、低血压、治疗时间段和血清乳酸后，替加环素并未显著改善 30 天死亡率（比值比：0.89；95%置信区间：0.25-3.12；0.853）。需要进行随机对照试验来确定替加环素在严重或难治性 CDI 中的疗效和安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc81/9211400/8372339cf887/aac.00001-22-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc81/9211400/8372339cf887/aac.00001-22-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc81/9211400/8372339cf887/aac.00001-22-f001.jpg

相似文献

1
Impact of Tigecycline on C. difficile Outcomes: Case Series and Propensity-Matched Retrospective Study.替加环素对艰难梭菌感染结局的影响：病例系列和倾向评分匹配回顾性研究。
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0000122. doi: 10.1128/aac.00001-22. Epub 2022 Jun 1.
2
Tigecycline for the treatment of patients with Clostridium difficile infection: an update of the clinical evidence.替加环素治疗艰难梭菌感染患者：临床证据的更新。
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1053-1058. doi: 10.1007/s10096-019-03756-z. Epub 2020 Jan 11.
3
Clostridioides difficile associated peritonitis in peritoneal dialysis patients - a case series based review of an under-recognized entity with therapeutic challenges.腹膜透析患者艰难梭菌相关性腹膜炎——基于病例系列的对一种未被充分认识且存在治疗挑战的疾病的综述
BMC Nephrol. 2020 Mar 4;21(1):76. doi: 10.1186/s12882-020-01734-8.
4
Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.替加环素在肿瘤患者艰难梭菌结肠炎管理中的应用及突破性感染病例系列
J Hosp Infect. 2017 Apr;95(4):426-432. doi: 10.1016/j.jhin.2016.12.018. Epub 2016 Dec 29.
5
Characteristics and predictors of treatment failure with intravenous tigecycline monotherapy among adult patients with severe Clostridioides (Clostridium) difficile infection: a single-centre observational cohort study.成人艰难梭菌（梭状芽孢杆菌）感染严重患者中单用替加环素静脉治疗失败的特征和预测因素：一项单中心观察性队列研究。
Diagn Microbiol Infect Dis. 2021 Feb;99(2):115231. doi: 10.1016/j.diagmicrobio.2020.115231. Epub 2020 Oct 6.
6
Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection.替加环素改变小鼠胃肠道微生物群会导致对艰难梭菌感染的易感性增加。
Antimicrob Agents Chemother. 2014 May;58(5):2767-74. doi: 10.1128/AAC.02262-13. Epub 2014 Mar 3.
7
Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.艰难梭菌感染患者口服万古霉素引起严重过敏反应。
Infection. 2013 Apr;41(2):579-82. doi: 10.1007/s15010-012-0328-4. Epub 2012 Sep 21.
8
The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.布拉氏酵母菌预防治疗对频繁使用易致艰难梭菌感染抗生素的住院患者艰难梭菌医院感染发病率的影响。
Clin Infect Dis. 2021 Nov 2;73(9):e2512-e2518. doi: 10.1093/cid/ciaa808.
9
The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.用替加环素联合疗法治疗的重度及重度复杂性艰难梭菌感染患者的结局：一项回顾性观察研究。
Intern Med J. 2018 Jun;48(6):651-660. doi: 10.1111/imj.13742.
10
Influence of Binary Toxin Gene Detection and Decreased Susceptibility to Antibiotics among Clostridioides difficile Strains on Disease Severity: a Single-Center Study.艰难梭菌菌株中二元毒素基因检测和抗生素敏感性降低对疾病严重程度的影响：一项单中心研究。
Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0048922. doi: 10.1128/aac.00489-22. Epub 2022 Jul 21.

引用本文的文献

1
Management of infection in patients with haematological malignancies and after cellular therapy: guidelines from 10th European Conference on Infections in Leukaemia (ECIL-10).血液系统恶性肿瘤患者及细胞治疗后感染的管理：第十届欧洲白血病感染会议（ECIL-10）指南
EClinicalMedicine. 2025 Aug 7;87:103371. doi: 10.1016/j.eclinm.2025.103371. eCollection 2025 Sep.
2
Management of severe and fulminant infection in adults.成人严重和暴发性感染的管理。
J Med Microbiol. 2025 Apr;74(4). doi: 10.1099/jmm.0.001991.
3
Third-Generation Tetracyclines: Current Knowledge and Therapeutic Potential.

本文引用的文献

1
Tigecycline for the treatment of patients with Clostridium difficile infection: an update of the clinical evidence.替加环素治疗艰难梭菌感染患者：临床证据的更新。
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1053-1058. doi: 10.1007/s10096-019-03756-z. Epub 2020 Jan 11.
2
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟：构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
3
Development and Validation of a Prediction Model for Mortality and Adverse Outcomes Among Patients With Peripheral Eosinopenia on Admission for Clostridium difficile Infection.
第三代四环素类药物：现有知识和治疗潜力。
Biomolecules. 2024 Jun 30;14(7):783. doi: 10.3390/biom14070783.
4
infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options.感染：历史、流行病学、风险因素、预防、临床表现、治疗和未来选择。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0013523. doi: 10.1128/cmr.00135-23. Epub 2024 Feb 29.
开发和验证入院时外周血嗜酸性粒细胞减少的艰难梭菌感染患者死亡率和不良结局预测模型。
JAMA Surg. 2018 Dec 1;153(12):1127-1133. doi: 10.1001/jamasurg.2018.3174.
4
Reduced Clostridium difficile Tests and Laboratory-Identified Events With a Computerized Clinical Decision Support Tool and Financial Incentive.计算机临床决策支持工具和经济激励减少艰难梭菌检测和实验室鉴定事件。
Infect Control Hosp Epidemiol. 2018 Jun;39(6):737-740. doi: 10.1017/ice.2018.53. Epub 2018 Apr 12.
5
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).临床实践指南：成人和儿童艰难梭菌感染：美国传染病学会（IDSA）和美国医疗保健流行病学学会（SHEA） 2017 年更新。
Clin Infect Dis. 2018 Mar 19;66(7):e1-e48. doi: 10.1093/cid/cix1085.
6
The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.用替加环素联合疗法治疗的重度及重度复杂性艰难梭菌感染患者的结局：一项回顾性观察研究。
Intern Med J. 2018 Jun;48(6):651-660. doi: 10.1111/imj.13742.
7
The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study.替加环素在艰难梭菌感染管理中的作用：一项回顾性队列研究。
Clin Microbiol Infect. 2018 Feb;24(2):180-184. doi: 10.1016/j.cmi.2017.06.005. Epub 2017 Jun 19.
8
Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Infection?辅助使用替加环素能否改善严重复杂非手术感染的预后？
Open Forum Infect Dis. 2017 Feb 10;4(1):ofw264. doi: 10.1093/ofid/ofw264. eCollection 2017 Winter.
9
Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.替加环素在肿瘤患者艰难梭菌结肠炎管理中的应用及突破性感染病例系列
J Hosp Infect. 2017 Apr;95(4):426-432. doi: 10.1016/j.jhin.2016.12.018. Epub 2016 Dec 29.
10
Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.静脉注射替加环素在严重艰难梭菌感染患者中的应用：一项回顾性观察队列研究。
Clin Microbiol Infect. 2016 Dec;22(12):990-995. doi: 10.1016/j.cmi.2016.08.017. Epub 2016 Sep 4.